Genome British Columbia Overview
- Investor Type
-
Venture Capital
- Status
-
Active
- Professionals
-
2
- Investments
-
28
- Portfolio
-
17
- Exits
-
7
Genome British Columbia General Information
Company Description
Founded in 2000, Genome British Columbia is a not-for-profit venture capital firm based in Vancouver, Canada. The firm seeks investments in early stage companies. The firm prefers to make investments in research, entrepreneurship, life sciences, health, forestry, fisheries, aquaculture, agri-food, energy, mining and environmental sectors.
Business Details
Website
www.genomebc.caYear Founded
Investor Status
Primary Investor Type
Corporate Office
- Suite 400-575
- West 8th Avenue
- Vancouver, British Columbia V5Z 0C4
- Canada
Genome British Columbia Investments (28)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Company Stage | Lead Partner |
|---|---|---|---|---|---|---|
| Arbutus Medical | 17-Feb-2026 | Later Stage VC | Surgical Devices | Generating Revenue | ||
| Maia Farms | 19-Jan-2026 | Other Commercial Products | Generating Revenue | |||
| Verdi | 15-May-2025 | Electronic Equipment and Instruments | Generating Revenue | |||
| Edna Explorer | 01-Apr-2025 | Business/Productivity Software | Generating Revenue | |||
| Arbutus Medical | 23-Jan-2024 | Surgical Devices | Generating Revenue | |||
| AG Bio | 08-Jun-2022 | Biotechnology | Generating Revenue | |||
| Avivo | 31-Mar-2022 | Biotechnology | Pre-Clinical Trials | |||
| Rehabtronics | 15-Mar-2022 | Therapeutic Devices | Generating Revenue | |||
| Stoko | 01-Jun-2021 | Early Stage VC | Therapeutic Devices | Generating Revenue | ||
| ALAViDA | 30-Jun-2020 | Seed Round | Other Healthcare Technology Systems | Generating Revenue |
Genome British Columbia Exits (7)
| Company Name | Exit Date | Exit Type | Exit Size |
|---|---|---|---|
| Microbiome Insights | 29-May-2025 | Merger/Acquisition | |
| Acuva | 19-Aug-2024 | ||
| LightIntegra Technology (Diagnostic Equipment) | 01-Nov-2021 | ||
| ALAViDA | 14-Oct-2021 | ||
| Precision Nanosystems | 01-Jun-2021 | ||
| Cyon Therapuetics | 01-May-2019 | Out of Business | |
| Anandia | 14-Aug-2018 | Merger/Acquisition |
Genome British Columbia Investments by Industry, Year, and Region
Genome British Columbia Co-Investors (36)
| Name | With | Exits | Lead Partner | Series | Industry |
|---|---|---|---|---|---|
| Threshold Impact | 2 |
|
|
||
| Crédit Mutuel Equity |
|
|
|||
| Keiretsu Forum |
|
|
|||
| NorthSpring Capital Partners |
|
|
|||
| Right Side Capital Management |
|
|
Genome British Columbia FAQs
-
What is Genome British Columbia?
Founded in 2000, Genome British Columbia is a not-for-profit venture capital firm based in Vancouver, Canada.
-
When was Genome British Columbia founded?
Genome British Columbia was founded in 2000.
-
Where is Genome British Columbia headquartered?
Genome British Columbia is headquartered in Vancouver, Canada.
-
What is Genome British Columbia's total asset value?
Genome British Columbia has around in total assets under management.
-
How many investments has Genome British Columbia made?
Genome British Columbia has made 28 investments.
-
What has Genome British Columbia invested in?
Genome British Columbia has made numerous investments in companies like Arbutus Medical, Maia Farms, and Verdi within the Surgical Devices, Commercial Products, and Electronic Equipment and Instruments industries.
-
What has Genome British Columbia invested in recently?
Genome British Columbia's latest investment was on 17-Feb-2026 in Arbutus Medical, a company within the Surgical Devices industry.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process